Literature DB >> 3951676

Effect of HI-6, applied into the cerebral ventricles, on the inhibition of brain acetylcholinesterase by soman in rats.

D Sket, M Brzin.   

Abstract

When applied to rats (intraperitoneally) immediately after subcutaneous injection of soman (120 micrograms/kg) HI-6 (100 mg/kg) protected about 40% of the activity of acetylcholinesterase (AChE) in the motor end plate region of the diaphragm but did not protect AChE in the brain. However, a partial protection of AChE in brain against inhibition by soman was obtained in anaesthetized, atropinized rats by the oxime injected into the cerebral ventricle 5 min before parenteral exposure to soman. The AChE activity in brain of rats pretreated with HI-6, analyzed 60 min after the injection of soman was between 10 and 19%, while that in non-protected animals did not exceed 1% of the control. The degree of protection of AChE in brain was dose-dependent. Large doses of HI-6 (greater than or equal to 100 micrograms) were tolerated by animals because of the pentobarbital anaesthesia which counteracted the lethal action of HI-6. The rate of "aging" of AChE in brain inhibited by soman was analyzed by intracerebroventricular injection of 200 micrograms of HI-6 at different time intervals after the subcutaneous injection of soman. A statistically-significant reactivation of inhibited AChE activity in brain was demonstrated when HI-6 was applied up to 20 min after soman. The protection and reactivation by HI-6 of both AChE in brain and AChE in muscle end plates in poisoning with soman appear to be quite similar.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3951676     DOI: 10.1016/0028-3908(86)90065-1

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  4 in total

1.  Attenuation of soman-induced lesions of skeletal muscle by acetylcholinesterase reactivating and non-reactivating antidotes.

Authors:  A Dekleva; D Sket; J Sketelj; M Brzin
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

2.  Pharmacokinetics and pharmacodynamics of the oxime HI6 in dogs.

Authors:  R Klimmek; P Eyer
Journal:  Arch Toxicol       Date:  1986-12       Impact factor: 5.153

3.  Studies on the decomposition of the oxime HI 6 in aqueous solution.

Authors:  P Eyer; W Hell; A Kawan; H Klehr
Journal:  Arch Toxicol       Date:  1986-12       Impact factor: 5.153

4.  Studies on the stability and decomposition of the Hagedorn-oxime HLö 7 in aqueous solution.

Authors:  P Eyer; B Ladstetter; W Schäfer; J Sonnenbichler
Journal:  Arch Toxicol       Date:  1989       Impact factor: 5.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.